Fate Therapeutics Inc
FATE
Market Cap$590.46M
Close$
$8.54
62.1% upside
Current Fair Value
62.1% upsideUndervalued by 62.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $590.46 Million |
|---|---|
| Enterprise Value | $275.29 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.64 |
| Beta | 2.79 |
| Outstanding Shares | 99,237,508 |
| Avg 30 Day Volume | 2,623,215 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.67 |
|---|---|
| PEG | 16.89 |
| Price to Sales | - |
| Price to Book Ratio | 1.76 |
| Enterprise Value to Revenue | 4.33 |
| Enterprise Value to EBIT | -1.44 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Fate Therapeutics Inc
CEO: William Rastetter